Mosaic ImmunoEngineering (CPMV) Interest Expenses (2010 - 2026)
Mosaic ImmunoEngineering (CPMV) posted quarterly Interest Expenses of $2467.0 for Q1 2026, little changed year-over-year from $2466.0 in Q1 2025, and down 2.14% quarter-over-quarter from $2521.0 in Q3 2025.
Mosaic ImmunoEngineering (CPMV) Interest Expenses (2010 - 2026) Analysis & Trends
Mosaic ImmunoEngineering's Interest Expenses history runs 11 years deep, the most recent figure standing at $2467.0 for Q1 2026.
- In Q1 2026, Interest Expenses changed 0.04% year-over-year to $2467.0; the TTM figure through Mar 2026 stood at $7481.0 (down 34.93% YoY), while the FY2025 annual figure was $3.6 million, up 1.38% from the prior year.
- Interest Expenses for Q1 2026 stood at $2467.0, down from $2521.0 in the prior quarter.
- The five-year high for Interest Expenses was $6214.0 in Q4 2024, with the low at $2466.0 in Q1 2025.
- The 3-year median for Interest Expenses is $2507.0 (2025), against an average of $3163.0.
- The sharpest annual moves came in 2025 and 2026: Interest Expenses declined 10.51% in 2025, then grew 0.04% in 2026.
- Mosaic ImmunoEngineering's Interest Expenses stood at $6214.0 in 2024, then slumped by 59.43% to $2521.0 in 2025, then slipped by 2.14% to $2467.0 in 2026.
- Business Quant data shows CPMV's Interest Expenses at $2467.0 in Q1 2026, $2521.0 in Q3 2025, and $2493.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.60 Bn | 130.75 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.93 Bn | 77.93 Bn | 3.93 Bn | 11.00 Mn |
| 3 | Argenx Se | 65.06 Bn | 59.88 Bn | 1.37 Bn | - |
| 4 | Moderna | 56.22 Bn | 51.08 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 42.03 Bn | 36.93 Bn | 1.53 Bn | 39.74 Mn |
| 6 | Alnylam Pharmaceuticals | 31.65 Bn | 28.34 Bn | 992.69 Mn | 82.05 Mn |
| 7 | BioNTech SE | 27.70 Bn | 9.31 Bn | 668.28 Mn | -4.89 Mn |
| 8 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 20.27 Mn |
| 9 | Royalty Pharma | 27.31 Bn | 26.48 Bn | - | 93.62 Mn |
| 10 | Mosaic ImmunoEngineering | 3.68 Mn | 3.68 Mn | - | 2,467.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2,467.00 |
| Mar 31, 2026 | 2,467.00 |
| Sep 30, 2025 | 2,521.00 |
| Sep 30, 2025 | 2,521.00 |
| Jun 30, 2025 | 2,493.00 |
| Jun 30, 2025 | 2,493.00 |
| Mar 31, 2025 | 2,466.00 |
| Mar 31, 2025 | 2,466.00 |
| Dec 31, 2024 | 6,214.00 |
| Dec 31, 2024 | 6,214.00 |
| Sep 30, 2024 | 2,817.00 |
| Sep 30, 2024 | 2,817.00 |
| May 31, 2019 | 3.69 Mn |
| May 31, 2019 | 3.69 Mn |
| May 31, 2018 | 3.69 Mn |
| May 31, 2018 | 3.69 Mn |
| Aug 31, 2015 | 20,000.00 |
| Aug 31, 2015 | 20,000.00 |
| Nov 30, 2014 | 103,125.00 |
| Nov 30, 2014 | 103,125.00 |